Literature DB >> 9636804

Immunotherapy as an effective tool in allergy treatment.

H J Malling1.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9636804     DOI: 10.1111/j.1398-9995.1998.tb04082.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  13 in total

Review 1.  Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.

Authors:  Harold S Nelson; Moises A Calderon; David I Bernstein; Thomas B Casale; Stephen R Durham; Jens S Andersen; Robert Esch; Linda S Cox; Hendrik Nolte
Journal:  Curr Allergy Asthma Rep       Date:  2017-03       Impact factor: 4.806

Review 2.  Minimising the risks of allergen-specific injection immunotherapy.

Authors:  H J Malling
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

Review 3.  Does allergen immunotherapy alter the natural course of allergic disorders?

Authors:  X Yang
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Authors:  Marek L Kowalski; Ignacio Ansotegui; Werner Aberer; Mona Al-Ahmad; Mubeccel Akdis; Barbara K Ballmer-Weber; Kirsten Beyer; Miguel Blanca; Simon Brown; Chaweewan Bunnag; Arnaldo Capriles Hulett; Mariana Castells; Hiok Hee Chng; Frederic De Blay; Motohiro Ebisawa; Stanley Fineman; David B K Golden; Tari Haahtela; Michael Kaliner; Connie Katelaris; Bee Wah Lee; Joanna Makowska; Ulrich Muller; Joaquim Mullol; John Oppenheimer; Hae-Sim Park; James Parkerson; Giovanni Passalacqua; Ruby Pawankar; Harald Renz; Franziska Rueff; Mario Sanchez-Borges; Joaquin Sastre; Glenis Scadding; Scott Sicherer; Pongsakorn Tantilipikorn; James Tracy; Vera van Kempen; Barbara Bohle; G Walter Canonica; Luis Caraballo; Maximiliano Gomez; Komei Ito; Erika Jensen-Jarolim; Mark Larche; Giovanni Melioli; Lars K Poulsen; Rudolf Valenta; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2016-10-12       Impact factor: 4.084

5.  Responders and nonresponders to pharmacotherapy and allergen immunotherapy.

Authors:  Marek Jakalski; Andrzej Bozek; G Walter Canonica
Journal:  Hum Vaccin Immunother       Date:  2019-06-21       Impact factor: 3.452

Review 6.  Recent advances in treatment strategies for atopic dermatitis.

Authors:  Thomas Christian Roos; Stefan Geuer; Sabine Roos; Harald Brost
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.

Authors:  Clara Padró; Diego Gutiérrez; Francisco Moreno; Antonio Parra; Manuel J Rial; Ramón Lleonart; Carla Torán-Barona; José L Justicia; Albert Roger
Journal:  Immun Inflamm Dis       Date:  2022-05

8.  Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.

Authors:  Iris Bellinghausen; Bettina Klostermann; Ingo Böttcher; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

9.  Human dendritic cells transfected with allergen-DNA stimulate specific immunoglobulin G4 but not specific immunoglobulin E production of autologous B cells from atopic individuals in vitro.

Authors:  Bettina König; Arnd Petersen; Iris Bellinghausen; Ingo Böttcher; Wolf-Meinhard Becker; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2007-10       Impact factor: 7.397

Review 10.  Immunotherapy for rhinitis.

Authors:  Hans-Jørgen Malling
Journal:  Curr Allergy Asthma Rep       Date:  2003-05       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.